Growth Metrics

Boston Scientific (BSX) Cash from Investing Activities (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -15.43%
Dec 31, 2025 -1.99%
Sep 30, 2025 55.42%
Jun 30, 2025 -125.20%
Mar 31, 2025 86.50%
Dec 31, 2024 -159.57%
Sep 30, 2024 -426.57%
Jun 30, 2024 4.91%
Mar 31, 2024 72.93%
Dec 31, 2023 -434.52%
Sep 30, 2023 76.55%
Jun 30, 2023 -73.55%
Mar 31, 2023 -164.48%
Dec 31, 2022 18.67%
Sep 30, 2022 -675.86%
Jun 30, 2022 98.16%
Mar 31, 2022 -241.43%
Dec 31, 2021 61.81%
Mar 31, 2021 148.30%
Dec 31, 2020 -13.95%
Sep 30, 2020 -118.64%
Jun 30, 2020 22.37%
Mar 31, 2020 -55.10%
Dec 31, 2019 98.76%
Sep 30, 2019 -539.03%
Jun 30, 2019 -51.22%
Mar 31, 2019 31.09%
Dec 31, 2018 10.12%
Sep 30, 2018 -34.83%
Jun 30, 2018 -183.82%
Mar 31, 2018 40.14%
Dec 31, 2017 -183.33%
Sep 30, 2017 78.71%
Jun 30, 2017 -242.14%
Mar 31, 2017 73.68%
Dec 31, 2016 -159.51%
Sep 30, 2016 -100.98%
Jun 30, 2016 -112.50%
Mar 31, 2016 71.76%
Dec 31, 2015 90.11%
Sep 30, 2015 -598.78%
Jun 30, 2015 -382.35%
Mar 31, 2015 38.55%
Dec 31, 2014 82.45%
Sep 30, 2014 -281.45%
Jun 30, 2014 -90.77%
Mar 31, 2014 82.09%
Dec 31, 2013 -397.26%
Sep 30, 2013 -160.71%
Jun 30, 2013 -154.55%
Mar 31, 2013 95.97%
Dec 31, 2012 -415.09%
Sep 30, 2012 71.66%
Jun 30, 2012 -183.33%
Mar 31, 2012 -29.41%
Dec 31, 2011 13.56%
Sep 30, 2011 28.05%
Jun 30, 2011 -108.47%
Mar 31, 2011 485.66%
Dec 31, 2010 -217.72%
Sep 30, 2010 -23.44%
Jun 30, 2010 13.51%
Mar 31, 2010 -23.33%
Dec 31, 2009 35.48%
Sep 30, 2009 24.39%
Jun 30, 2009 76.21%